UTAH MEDICAL PRODUCTS INC — Form 8-K
Filed November 3, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 28/100
What the filing says
Utah Medical Products' Board approved a quarterly cash dividend of $0.315 per share, payable January 5, 2027 to shareholders of record December 17, 2026. This represents a 1.6% increase from the prior quarterly dividend. The company continues its regular dividend practice.
Why this rating
Modest dividend increase signals financial health and capital allocation confidence, but 1.6% raise is routine. Immaterial to $168M market-cap company.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.